105 related articles for article (PubMed ID: 9757979)
1. The safety of omeprazole during pregnancy: a multicenter prospective controlled study.
Lalkin A; Loebstein R; Addis A; Ramezani-Namin F; Mastroiacovo P; Mazzone T; Vial T; Bonati M; Koren G
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):727-30. PubMed ID: 9757979
[TBL] [Abstract][Full Text] [Related]
2. Cisapride use during human pregnancy: a prospective, controlled multicenter study.
Bailey B; Addis A; Lee A; Sanghvi K; Mastroiacovo P; Mazzone T; Bonati M; Paolini C; Garbis H; Val T; De Souza CF; Matsui D; Schechtman AS; Conover B; Lau M; Koren G
Dig Dis Sci; 1997 Sep; 42(9):1848-52. PubMed ID: 9331146
[TBL] [Abstract][Full Text] [Related]
3. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.
Djulus J; Koren G; Einarson TR; Wilton L; Shakir S; Diav-Citrin O; Kennedy D; Voyer Lavigne S; De Santis M; Einarson A
J Clin Psychiatry; 2006 Aug; 67(8):1280-4. PubMed ID: 16965209
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcome after gestational exposure to terfenadine: A multicenter, prospective controlled study.
Loebstein R; Lalkin A; Addis A; Costa A; Lalkin I; Bonati M; Koren G
J Allergy Clin Immunol; 1999 Nov; 104(5):953-6. PubMed ID: 10550738
[TBL] [Abstract][Full Text] [Related]
5. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes.
Ruigómez A; García Rodríguez LA; Cattaruzzi C; Troncon MG; Agostinis L; Wallander MA; Johansson S
Am J Epidemiol; 1999 Sep; 150(5):476-81. PubMed ID: 10472947
[TBL] [Abstract][Full Text] [Related]
6. Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy.
Källén BA
Eur J Obstet Gynecol Reprod Biol; 2001 May; 96(1):63-8. PubMed ID: 11311763
[TBL] [Abstract][Full Text] [Related]
7. Epilepsy, pregnancy, and major birth anomalies: an Italian prospective, controlled study.
Tanganelli P; Regesta G
Neurology; 1992 Apr; 42(4 Suppl 5):89-93. PubMed ID: 1574184
[TBL] [Abstract][Full Text] [Related]
8. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy.
Viinikainen K; Heinonen S; Eriksson K; Kälviäinen R
Epilepsia; 2006 Jan; 47(1):186-92. PubMed ID: 16417548
[TBL] [Abstract][Full Text] [Related]
9. Birth outcomes in pregnant women taking fluoxetine.
Chambers CD; Johnson KA; Dick LM; Felix RJ; Jones KL
N Engl J Med; 1996 Oct; 335(14):1010-5. PubMed ID: 8793924
[TBL] [Abstract][Full Text] [Related]
10. Prospective controlled study of hydroxyzine and cetirizine in pregnancy.
Einarson A; Bailey B; Jung G; Spizzirri D; Baillie M; Koren G
Ann Allergy Asthma Immunol; 1997 Feb; 78(2):183-6. PubMed ID: 9048526
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study.
Bar-Oz B; Moretti ME; Bishai R; Mareels G; Van Tittelboom T; Verspeelt J; Koren G
Am J Obstet Gynecol; 2000 Sep; 183(3):617-20. PubMed ID: 10992182
[TBL] [Abstract][Full Text] [Related]
12. Exercise during pregnancy in normal-weight women and risk of preterm birth: a systematic review and meta-analysis of randomized controlled trials.
Di Mascio D; Magro-Malosso ER; Saccone G; Marhefka GD; Berghella V
Am J Obstet Gynecol; 2016 Nov; 215(5):561-571. PubMed ID: 27319364
[TBL] [Abstract][Full Text] [Related]
13. Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study.
Berkovitch M; Mazzota P; Greenberg R; Elbirt D; Addis A; Schuler-Faccini L; Merlob P; Arnon J; Stahl B; Magee L; Moretti M; Ornoy A
Am J Perinatol; 2002 Aug; 19(6):311-6. PubMed ID: 12357422
[TBL] [Abstract][Full Text] [Related]
14. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry.
Cardonick E; Usmani A; Ghaffar S
Am J Clin Oncol; 2010 Jun; 33(3):221-8. PubMed ID: 19745695
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study.
Loebstein R; Addis A; Ho E; Andreou R; Sage S; Donnenfeld AE; Schick B; Bonati M; Moretti M; Lalkin A; Pastuszak A; Koren G
Antimicrob Agents Chemother; 1998 Jun; 42(6):1336-9. PubMed ID: 9624471
[TBL] [Abstract][Full Text] [Related]
16. Treatment of breast cancer during pregnancy: an observational study.
Loibl S; Han SN; von Minckwitz G; Bontenbal M; Ring A; Giermek J; Fehm T; Van Calsteren K; Linn SC; Schlehe B; Gziri MM; Westenend PJ; Müller V; Heyns L; Rack B; Van Calster B; Harbeck N; Lenhard M; Halaska MJ; Kaufmann M; Nekljudova V; Amant F
Lancet Oncol; 2012 Sep; 13(9):887-96. PubMed ID: 22902483
[TBL] [Abstract][Full Text] [Related]
17. Obstetric and perinatal outcomes of singleton pregnancies conceived via assisted reproductive technology complicated by gestational diabetes mellitus: a prospective cohort study.
Kouhkan A; Khamseh ME; Pirjani R; Moini A; Arabipoor A; Maroufizadeh S; Hosseini R; Baradaran HR
BMC Pregnancy Childbirth; 2018 Dec; 18(1):495. PubMed ID: 30547777
[TBL] [Abstract][Full Text] [Related]
18. The safety of proton pump inhibitors in pregnancy.
Nielsen GL; Sørensen HT; Thulstrup AM; Tage-Jensen U; Olesen C; Ekbom A
Aliment Pharmacol Ther; 1999 Aug; 13(8):1085-9. PubMed ID: 10468685
[TBL] [Abstract][Full Text] [Related]
19. A multicenter prospective study of neonatal outcomes at less than 32 weeks associated with indications for maternal admission and delivery.
Garite TJ; Combs CA; Maurel K; Das A; Huls K; Porreco R; Reisner D; Lu G; Bush M; Morris B; Bleich A;
Am J Obstet Gynecol; 2017 Jul; 217(1):72.e1-72.e9. PubMed ID: 28267444
[TBL] [Abstract][Full Text] [Related]
20. The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study.
Diav-Citrin O; Arnon J; Shechtman S; Schaefer C; van Tonningen MR; Clementi M; De Santis M; Robert-Gnansia E; Valti E; Malm H; Ornoy A
Aliment Pharmacol Ther; 2005 Feb; 21(3):269-75. PubMed ID: 15691301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
